Neurokinin-1 receptor antagonists as novel antidepressants: trials and tribulations.

Based upon animal experiments and early clinical trials, neurokinin-1 receptor antagonists showed promise as novel antidepressants. Subsequently, however, more extensive clinical trials did not reveal evidence of efficacy in depression. The development of novel antidepressants will require a better...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Hafizi, S, Chandra, P, Cowen, J
Materialtyp: Journal article
Språk:English
Publicerad: 2007